Literature DB >> 20054289

SCORE should be preferred to Framingham to predict cardiovascular death in French population.

Ivanny Marchant1, Jean-Pierre Boissel, Behrouz Kassaï, Theodora Bejan, Jacques Massol, Chrystelle Vidal, Emmanuel Amsallem, Florence Naudin, Pilar Galan, Sébastien Czernichow, Patrice Nony, François Gueyffier.   

Abstract

BACKGROUND: Numerous studies have examined the validity of available scores to predict the absolute cardiovascular risk.
DESIGN: We developed a virtual population based on data representative of the French population and compared the performances of the two most popular risk equations to predict cardiovascular death: Framingham and SCORE.
METHODS: A population was built based on official French demographic statistics and summarized data from representative observational studies. The 10-year coronary and cardiovascular death risk and their ratio were computed for each individual by SCORE and Framingham equations. The resulting rates were compared with those derived from national vital statistics.
RESULTS: Framingham overestimated French coronary deaths by 2.8 in men and 1.9 in women, and cardiovascular deaths by 1.5 in men and 1.3 in women. SCORE overestimated coronary death by 1.6 in men and 1.7 in women, and underestimated cardiovascular death by 0.94 in men and 0.85 in women. Our results revealed an exaggerated representation of coronary among cardiovascular death predicted by Framingham, with coronary death exceeding cardiovascular death in some individual profiles. Sensitivity analyses gave some insights to explain the internal inconsistency of the Framingham equations.
CONCLUSION: Evidence is that SCORE should be preferred to Framingham to predict cardiovascular death risk in French population. This discrepancy between prediction scores is likely to be observed in other populations. To improve the validation of risk equations, specific guidelines should be issued to harmonize the outcomes definition across epidemiologic studies. Prediction models should be calibrated for risk differences in the space and time dimensions.

Entities:  

Mesh:

Year:  2009        PMID: 20054289     DOI: 10.1097/HJR.0b013e32832da006

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  5 in total

1.  Comparison of an effect-model-law-based method versus traditional clinical practice guidelines for optimal treatment decision-making: application to statin treatment in the French population.

Authors:  Riad Kahoul; François Gueyffier; Emmanuel Amsallem; Margaret Haugh; Ivanny Marchant; François-Henri Boissel; Jean-Pierre Boissel
Journal:  J R Soc Interface       Date:  2014-11-06       Impact factor: 4.118

2.  The global risk approach should be better applied in French hypertensive patients: a comparison between simulation and observation studies.

Authors:  Ivanny Marchant; Patrice Nony; Michel Cucherat; Jean-Pierre Boissel; S Randall Thomas; Theodora Bejan-Angoulvant; Alexandra Laugerotte; Riad Kahoul; François Gueyffier
Journal:  PLoS One       Date:  2011-03-03       Impact factor: 3.240

Review 3.  Effect model law: an approach for the implementation of personalized medicine.

Authors:  Jean-Pierre Boissel; Riad Kahoul; Draltan Marin; François-Henri Boissel
Journal:  J Pers Med       Date:  2013-08-15

4.  Comparison of the Framingham risk and SCORE models in predicting the presence and severity of coronary artery disease considering SYNTAX score.

Authors:  Zeki Yüksel Günaydın; Ahmet Karagöz; Osman Bektaş; Ahmet Kaya; Tuncay Kırış; Güney Erdoğan; Turgay Işık; Erkan Ayhan
Journal:  Anatol J Cardiol       Date:  2015-06-30       Impact factor: 1.596

5.  High Risk versus Proportional Benefit: Modelling Equitable Strategies in Cardiovascular Prevention.

Authors:  Ivanny Marchant; Jean-Pierre Boissel; Patrice Nony; François Gueyffier
Journal:  PLoS One       Date:  2015-11-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.